Dr. Wilson Ko at Advanced Eye Care in NYC Now Offers AcrySof® IQ VivityTM – the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens for Cataract Patients in the U.S.
• Vivity™ is a presbyopia-mitigating intraocular lens option that provides clear vision at distance and intermediate, with functional near vision.
• Available to patients in New York who are interested in restoring and improving their vision or desiring more spectacle independence compared to a monofocal IOL.
New York, NY April, 2021 – Advanced Eye Care is excited to announce that Alcon’s AcrySof® IQ Vivity™ cataract replacement lens is now available at our practice in New York City. As a proud Alcon partner, Dr. Wilson Ko is thrilled to offer Vivity™, the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL), to U.S. cataract patients. Cataracts are the most common cause of vision loss globally, and in the U.S. nine in 10 Americans develop cataracts by the time they’re 65.
The AcrySof® IQ Vivity™ IOL is a new lens option for the more than four million Americans who undergo cataract surgery every year and are looking to correct their vision at the time of surgery. The standard cataract replacement lens, which is also called a monofocal lens, allows you to see far away. With Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it, the Vivity™ lens allows patients to see clearly far away and at arm’s length, while still providing functional vision up close. In a clinical study, 96 patients reported about their experience 6 months after receiving the Vivity™ lens, and in bright light, 94% of patients reported good or very good vision far away without glasses and 92% reported good or very good vision at arm’s length without glasses.
“At Advanced Eye Care, we are dedicated to ensuring patients receive the highest quality of eye care and the latest technological advancements,” said Dr. Wilson Ko. “By offering the recently launched Vivity™, we now have expanded our IOL options for cataract patients and will be able to help many more patients restore their vision and meet their desired lifestyle needs. We started implanting them in January/February of 2021 and patients are happy with the results.”
Vivity™ meets the needs of patients who are interested in some spectacle independence and similar rates of glares and halos compared to a monofocal lens. Clinical trial results also show that Vivity™ provided a continuous extended range of vision of 20/20 at distance and greater than 20/25 at intermediate – key benefits Advanced Eye Care cataract patients have been looking for.
Dr. Ko is now offering this innovative technology for patients. For patients interested in learning more about Vivity™, please call (212) 732-0073 or visit https://advancedeyecarevision.com to schedule an appointment and speak with your eye care professional about your options.
A cataract is a cloudy area in the natural lens of the eye that affects vision. As a cataract develops, the eye’s lens gradually becomes hard and cloudy allowing less light to pass through, which makes it more difficult to see. The vast majority of cataracts result from normal aging, but radiation exposure, taking steroids, diabetes and eye trauma can accelerate their development. Cataracts are the most common age-related eye condition and the leading cause of preventable blindness. Twenty million people in the U.S. age 40 and older have cataracts. Cataracts are treated by removing the eye’s cloudy natural lens and surgically replacing it with an intraocular lens or IOL. More than 98 percent of cataract surgeries are considered successful, and patients typically can return to their normal routines within 24 hours.
Presbyopia is a common, age-related vision condition in which people have difficulty focusing on things up close. It involves the gradual loss of the eye’s ability to focus on close objects, such as smartphones, computers, books, and menus. Almost everyone will experience presbyopia to some degree as they age, with symptoms often first appearing as an individual enters their 40s and continues to worsen into their 60s. In the U.S., an estimated 112 million people experience vision issues due to presbyopia – a number that’s expected to continue increasing. The condition is not a disease, so it cannot be cured; however, there are safe and effective ways to correct presbyopia, including eyeglasses, contact lenses, or refractive surgery.
The non-diffractive AcrySof® IQ Vivity™ Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof® IQ Vivity™ IOL) is a UV-absorbing and blue light filtering foldable intraocular lens (IOL). This IOL, compared to a monofocal IOL, provides an extended range of vision from distance to near without increasing the incidence of visual disturbances.
Potential side effects: As with any surgery, there is an implicit risk, whether or not the IOL is implanted. The complications of the IOL implantation surgery ranges from minor side effects (usually temporary) to serious complications. Patients with previous illnesses or disorders (such as chronic infections of the eye or eyelids, or diabetes) may present a higher risk of complications. Temporary surgical complications include, but are not limited to, reactions to medications such as irritation or mild allergic response, bleeding, redness, itching of the eye, sensitivity to light, swelling, Corneal edema (swelling of the cornea), problems with the iris, cell growth in the IOL, and an increase temporary eye pressure. There is a small risk of needing further surgical treatment (such as IOL replacement implanted by a different one or surgery to improve vision) after the implantation of the initial IOL.
AcrySof® IQ Vivity™ Extended Vision Family of IOLs
IMPORTANT PRODUCT INFORMATION:
CAUTION: Restricted by law to sale by or on the order of a physician.
DESCRIPTION: The AcrySof® IQ Vivity™ Extended Vision IOL is a type of IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. The AcrySof® IQ Vivity™ Extended Vision IOL provides clear distance vision (e.g., for watching children playing in the backyard). In addition, the AcrySof® IQ Vivity™ Extended Vision IOL allows for better intermediate (working on a computer, applying makeup or shaving) and some near (reading, knitting) vision compared to what a monofocal IOL would provide. The AcrySof® IQ Vivity™ IOL is not a multifocal IOL, as it uses new Wavefront-Shaping technology to provide a broader range of vision.
There is a chance you may still need glasses for distance, intermediate, and/or near vision. You will get the full benefit of the AcrySof® IQ Vivity™ Extended Vision IOL when it is implanted in both eyes. Please discuss with your eye doctor whether this is the right IOL for you.
Potential Side Effects: There are some side effects that can be associated with the design of IOLs that provide a broader range of vision, which may be worse than with a monofocal IOL. These side effects include visual disturbances such as glare, rings around lights, starbursts, and a decrease in the ability to distinguish objects from their background, especially in dim lighting. These side effects may make it more difficult to see in some situations.
Contrast sensitivity, an important measure of visual function, is the ability to distinguish objects from their background, especially in dim lighting. In the AcrySof® IQ Vivity™ IOL clinical study, contrast sensitivity in dim lighting was reduced in patients who received the AcrySof® IQ Vivity™ IOL compared to those who received the Monofocal IOL.
A toric IOL corrects astigmatism only when it is placed in the correct position in the eye. Some patients may have some level of astigmatism remaining after IOL placement, especially if they had a lot of astigmatism before surgery. There is also a possibility that the toric IOL could be placed incorrectly or could move within the eye. As with any toric IOL that provides an extended range of vision, if the lens is not positioned correctly in your eye, or if the amount of astigmatism to be corrected is calculated incorrectly, you may experience poor vision, you may need to wear glasses to see clearly at all distances, or you may need additional surgery to reposition or replace the IOL.
ATTENTION: As with any surgery, there are risks involved. Prior to surgery, ask your eye doctor to provide you with the Patient Information Brochure for the proposed AcrySof® IQ Vivity™ Extended Vision IOL to be implanted. This document will further inform you of the risks and benefits associated with this IOL. Discuss any questions about possible risks and benefits with your eye doctor, as well as your medical condition and any eye disease you may have.
1. AcrySof® IQ Vivity™ Extended Vision IOL DFU. Alcon Laboratories, Inc.; 2020.
2. Hood C. Cataract. Kellogg Eye Center website. Accessed April 23, 2019. https://www.umkelloggeye.org/conditions-treatments/cataract
3. Market Scope. 2017 Ophthalmic Surgical Instrument Report.
4. Alcon Data on File, 2019.
5. National Institutes of Health (NIH), National Eye Institute (NEI). Facts About Cataracts. Available at: http://www.nei.nih.gov/health/cataract/cataract _facts.asp.
6. Centers for Disease Control and Prevention, Vision Health Initiative. Accessed July 19, 2019. Available at: https://www.cdc.gov/visionhealth/basics/ced/index.html.
7. Cleveland Clinic, Cataracts. Accessed August 12, 2019. Available at: https://my.clevelandclinic.org/health/diseases/8589-cataracts.
8. Mayo Clinic, Presbyopia. Accessed August 12, 2019. Available at: https://www.mayoclinic.org/diseases-conditions/presbyopia/symptoms-causes/syc-20363328.
9. American Optometric Association: Optometric Clinical Practice Guideline, Care of the Patient with Presbyopia. Accessed August 12, 2019. Available at: https://www.aoa.org/documents/optometrists/CPG-17.pdf.